Related Experiment Video
Updated: Jul 18, 2025

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
Lysosomal storage disorders: Clinical and therapeutic aspects
1Department of Medicine (Clinical Genetics), National Center for Inherited Metabolic Disorders, Mater Misericordiae University Hospital, Dublin, Ireland; Department of Medicine (Genetics), University College of Dublin School of Medicine, Dublin, Ireland.
Lysosomal storage disorders are inherited metabolic diseases due to enzyme deficiencies. This review covers their defects, symptoms, and therapeutic outcomes including enzyme replacement and transplantation.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Lysosomal storage disorders (LSDs) are a group of rare, inherited metabolic diseases.
- They result from genetic defects leading to enzyme deficiencies within lysosomes.
- This impairs the breakdown of cellular waste products, causing accumulation and cellular damage.
Conclusions:
- Understanding the specific enzyme deficiencies and substrate accumulation is crucial for LSD management.
- Therapeutic strategies like ERT, HSCT, SRT, and EET offer potential for clinical improvement.
- Personalized treatment approaches are essential for optimizing outcomes in patients with lysosomal storage disorders.
Related Concept Videos
Lysosomal Hydrolases
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Inborn Errors of Metabolism
Parkinson's Disease: Overview
Lysosomes
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...

